LUIS
FIGUERO PÉREZ
Investigador en el periodo 2019-2023
![Foto de LUIS](/img/nophoto.png)
![Foto de Hospital Universitario de Salamanca](/img/noimage_org.png)
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (19)
2024
-
Acute pulmonary embolism masking a pulmonary artery sarcoma
Medicina Clinica
-
COMPLICATIONS SECONDARY TO THE USE OF SGLT2 INHIBITORS IN ONCOLOGICAL PATIENTS: A SERIES OF 5 CASES
European Journal of Case Reports in Internal Medicine, Vol. 11, Núm. 1
-
Cáncer de mama
Oncología clínica (Arán Ediciones), pp. 203-226
-
Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review
Chinese Clinical Oncology, Vol. 13, Núm. 3
-
Tratamiento Sistémico del Cáncer (II): hormonoterapia
Oncología clínica (Arán Ediciones), pp. 89-99
2023
-
Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
Cancers, Vol. 15, Núm. 17
-
Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»
Revista Espanola de Geriatria y Gerontologia
2022
-
Acquired haemophilia A secondary to metastatic prostate cancer
Medicina Clinica
-
Acute esophageal necrosis induced by immune checkpoint inhibitors
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 3, pp. 182-183
-
Cancer and elderly: Two incompatible concepts for intensive care?
Revista Espanola de Geriatria y Gerontologia
-
Ileal plasmablastic lymphoma presenting as intestinal occlusion in an HIV-negative patient with chronic lymphocytic leukemia
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 4, pp. 242-243
-
Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy
Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88
-
Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis
Biomedicines, Vol. 10, Núm. 2
2021
-
Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications
Biomolecules, Vol. 11, Núm. 2, pp. 1-16
-
Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors
Life, Vol. 11, Núm. 12
-
Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies
Journal of Clinical Medicine, Vol. 10, Núm. 9
-
The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives
Applied Sciences (Switzerland), Vol. 11, Núm. 18
2020
-
Management of Febrile Neutropenia Associated with SARS-CoV-2 Infection in a Patient with Cancer
JCO Oncology Practice
-
Reply to A. Lasagna et al
JCO Oncology Practice